Literature DB >> 1466156

Histology and immunocytochemistry of differentiated thyroid carcinomas do not predict radioiodine uptake: a clinicomorphological study of 62 recurrent or metastatic tumours.

B Bätge1, H Dralle, B Padberg, B von Herbay, S Schröder.   

Abstract

Sixty-two metastases or recurrences of differentiated thyroid carcinomas were investigated using conventional histology and immunocytochemistry for thyroglobulin (TG), thyroxine (T4) and triiodothyronine (T3). In each patient, 131I total body scans had been performed 4-10 weeks before surgery. Twenty-seven of the 62 tumours exhibited a predominance of follicles (A1), while 35 either exclusively or predominantly consisted of papillae or, in the case of follicular carcinomas, were predominantly trabecular or solid in structure (A2). TG and T4 immunoreactivity was observed in 60 cases, only 4 of these also expressing T3. Positive radioiodine uptake (RIU) was noted in 27 of 62 (44%) cases (A1:18/27 = 67%; A2:9/35 = 26%), 25 of which showed intraluminal TG and T4 positivity. Two follicular carcinomas showing RIU lacked follicular lumina, but exhibited strong diffuse cytoplasmic positivity for both TG and T4. In another 95 differentiated thyroid carcinomas, the structure of primary and secondary lesions was assessed. Of these, 27 (28%) showed a discordant pattern (A1/A2 or A2/A1) when comparing the structure of primary and secondary lesions. Our data suggest that differentiated thyroid carcinomas show a dissociation of TG/T4 expression and RIU, defects of iodine uptake and storage being found more frequently than a depression of TG and T4 synthesis. Intact synthesis of TG and T4, but not of T3 may be regarded as a prerequisite for RIU. Positive RIU is based on the presence of mature neoplastic follicles containing TG and T4 immunoreactive colloid and among follicular carcinomas, positive RIU may be encountered in neoplasms lacking follicular lumina but exhibiting strong cytoplasmic TG and T4 staining. Finally, the RIU of recurrent and metastatic PC and FC is not predictable from histological features of the primaries.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466156     DOI: 10.1007/bf01606882

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  12 in total

1.  Histochemical demonstration of thyroxine, triiodothyronine, and thyroglobulin in the primary lesion of thyroid carcinoma, and its predictability for radioiodine uptake by metastatic lesions.

Authors:  T Kodama; Y Fujimoto; T Obara; Y Ito; K Kusakabe; A Hirayama
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

2.  Thyrotrophin-induced aggregation and reorganization into follicles of isolated porcine-thyroid cells. 1. Mechanism of action of thyrotrophin and metabolic properties.

Authors:  S Lissitzky; G Fayet; A Giraud; B Verrier; J Torresani
Journal:  Eur J Biochem       Date:  1971-12-22

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Polarized multicellular structures designed for the in vitro study of thyroid cell function and polarization.

Authors:  J Mauchamp; M Chambard; J Gabrion; B Verrier
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Morphometric lightmicroscopic and immunohistochemical analyses of differentiated thyroid carcinomas.

Authors:  H Dralle; W Böcker; G Nielson; W Rehpenning
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1982

6.  Sequential serum thyroglobulin determinations, 131I scans, and 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer.

Authors:  A B Schneider; B R Line; J M Goldman; J Robbins
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

7.  Simultaneous detection of thyroglobulin (Tg), thyroxine (T4), and Triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method.

Authors:  A Kawaoi; T Okano; N Nemoto; Y Shiina; T Shikata
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

8.  Papillary thyroid carcinomas. Morphology and prognosis.

Authors:  J Tscholl-Ducommun; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

9.  Thyrotrophin stimulation of adenylate cyclase and iodine uptake in human differentiated thyroid cancer.

Authors:  C Thomas-Morvan; P Carayon; M Schlumberger; A Vignal; M Tubiana
Journal:  Acta Endocrinol (Copenh)       Date:  1982-09

10.  Thyrotrophin receptors, tumour radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers.

Authors:  C J Edmonds; J C Kermode
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

View more
  1 in total

1.  Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer.

Authors:  L M Haslinghuis; E P Krenning; W W De Herder; A E Reijs; D J Kwekkeboom
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.